Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D

Nutrients

Volumn 7, Issue 10, 2015, Pages 8251-8260

  Wei, Ran ^a   Christakos, Sylvia ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune disease; Cathelicidin; Vitamin D

Indexed keywords

CALCITRIOL; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYTOKINE; GAMMA INTERFERON; HISTONE DEACETYLASE; INTERLEUKIN 17; INTERLEUKIN 2; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN; RETINOID X RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; AUTOCRINE EFFECT; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; DENDRITIC CELL; EPITHELIUM CELL; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; HUMAN; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY CELL; INNATE IMMUNITY; LYMPHOCYTE; MONOCYTE; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PARACRINE SIGNALING; PROTEIN DEGRADATION; REGULATORY MECHANISM; RESPIRATORY SYSTEM; REVIEW; STAPHYLOCOCCUS AUREUS; ANIMAL; HOMEOSTASIS; IMMUNITY; KNOCKOUT MOUSE; MOUSE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; CALCITRIOL; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, CALCITRIOL; VITAMIN D;

EID: 84942763519     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7105392     Document Type: Review

References (69)

1. Christakos, S.; Ajibade, D.V.; Dhawan, P.; Fechner, A.J.; Mady, L.J. Vitamin D: Metabolism. Rheum. Dis. Clin. N. Am. 2012, 38, 1–11. [CrossRef] [PubMed]
2. Cheng, J.B.; Levine, M.A.; Bell, N.H.; Mangelsdorf, D.J.; Russell, D.W. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. USA 2004, 101, 7711–7715. [CrossRef] [PubMed]
3. Zhu, J.G.; Ochalek, J.T.; Kaufmann, M.; Jones, G.; Deluca, H.F. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc. Natl. Acad. Sci. USA 2013, 110, 15650–15655. [CrossRef] [PubMed]
4. Christakos, S. Vitamin D gene regulation. In Principles of Bone Biology, 3rd ed.; Bilezikian, J.P., Raisz, L.G., Eds.; Elsevier: San Diego, CA, USA, 2008; Volume 1, pp. 770–794.
5. Haussler, M.R.; Whitfield, G.K.; Kaneko, I.; Haussler, C.A.; Hsieh, D.; Hsieh, J.C.; Jurutka, P.W. Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 2013, 92, 77–98. [CrossRef] [PubMed]
6. Pike, J.W.; Meyer, M.B. Fundamentals of vitamin D hormone-regulated gene expression. J. Steroid Biochem. Mol. Biol. 2014, 144, 5–11. [CrossRef] [PubMed]
7. Lai, Y.; Gallo, R.L. AMPed up immunity: How antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009, 30, 131–141. [CrossRef] [PubMed]
8. Larrick, J.W.; Hirata, M.; Balint, R.F.; Lee, J.; Zhong, J.; Wright, S.C. Human CAP18: A novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 1995, 63, 1291–1297. PubMed]
9. Vandamme, D.; Landuyt, B.; Luyten, W.; Schoofs, L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 2012, 280, 22–35. [CrossRef] [PubMed]
10. Henzler, W.K.; Lee, D.K.; Ramamoorthy, A. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry 2003, 42, 6545–6558. [CrossRef] [PubMed]
11. Wang, T.T.; Nestel, F.P.; Bourdeau, V.; Nagai, Y.; Wang, Q.; Liao, J.; Tavera-Mendoza, L.; Lin, R.; Hanrahan, J.W.; Mader, S.et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173, 2909–2912. [CrossRef] [PubMed]
12. Gombart, A.F.; Borregaard, N.; Koeffler, H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19, 1067–1077. [CrossRef] [PubMed]
13. Yim, S.; Dhawan, P.; Ragunath, C.; Christakos, S.; Diamond, G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D3. J. Cyst. Fibros. 2007, 6, 403–410. [CrossRef] [PubMed]
14. White, J.H. Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: Past, present and future. J. Steroid Biochem. Mol. Biol. 2010, 121, 234–238. [CrossRef] [PubMed]
15. Schauber, J.; Dorschner, R.A.; Yamasaki, K.; Brouha, B.; Gallo, R.L. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 2006, 118, 509–519. [CrossRef] [PubMed]
16. Liu, N.; Kaplan, A.T.; Low, J.; Nguyen, L.; Liu, G.Y.; Equils, O.; Hewison, M. Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol. Reprod. 2009, 80, 398–406. [CrossRef] [PubMed]
17. Liu, P.T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B.H.; Krutzik, S.R.; Ochoa, M.T.; Schauber, J.; Wu, K.; Meinken, C et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311, 1770–1773. [CrossRef] [PubMed]
18. Schauber, J.; Oda, Y.; Buchau, A.S.; Yun, Q.C.; Steinmeyer, A.; Zugel, U.; Bikle, D.D.; Gallo, R.L. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. J. Investig. Dermatol. 2008, 128, 816–824. [CrossRef] [PubMed]
19. Dhawan, P.; Wei, R.; Sun, C.; Gombart, A.F.; Koeffler, H.P.; Diamond, G.; Christakos, S. C/EBPalpha and the vitamin D receptor cooperate in the regulation of cathelicidin in lung epithelial cells. J. Cell Physiol. 2015, 230, 464–472. [CrossRef] [PubMed]
20. Termen, S.; Tollin, M.; Rodriguez, E.; Sveinsdottir, S.H.; Johannesson, B.; Cederlund, A.; Sjovall, J.; Agerberth, B.; Gudmundsson, G.H. PU.1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Mol. Immunol. 2008, 45, 3947–3955. [CrossRef] [PubMed]
21. Steinmann, J.; Halldorsson, S.; Agerberth, B.; Gudmundsson, G.H. Phenylbutyrate induces antimicrobial peptide expression. Antimicrob. Agents Chemother. 2009, 53, 5127–5133. [CrossRef] [PubMed]
22. Liu, P.T.; Schenk, M.; Walker, V.P.; Dempsey, P.W.; Kanchanapoomi, M.; Wheelwright, M.; Vazirnia, A.; Zhang, X.; Steinmeyer, A.; Zugel, U. et al. Convergence of IL-1 and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE 2009, 4, e5810. [CrossRef] [PubMed]
23. Sly, L.M.; Lopez, M.; Nausseef, W.M.; Reiner, N.E. 1,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem. 2001, 276, 35482–35493. [CrossRef] [PubMed]
24. Shin, D.M.; Yuk, J.M.; Lee, H.M.; Lee, S.H.; Son, J.W.; Harding, C.V.; Kim, J.M.; Modlin, R.L.; Jo, E.K. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell. Microbiol. 2010, 12, 1648–1665. [CrossRef] [PubMed]
25. Mora, J.R.; Iwata, M.; von Andrian, U.H. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat. Rev. Immunol. 2008, 8, 685–698. [CrossRef] [PubMed]
26. Chun, R.F.; Liu, P.T.; Modlin, R.L.; Adams, J.S.; Hewison, M. Impact of vitamin D on immune function: Lessons learned from genome-wide analysis. Front. Physiol. 2014, 5. [CrossRef] [PubMed]
27. Cantorna, M.T. Mechanisms underlying the effect of vitamin D on the immune system. Proc. Nutr. Soc. 2010, 69, 286–289. [CrossRef] [PubMed]
28. Lemire, J.M.; Adams, J.S.; Kermani-Arab, V.; Bakke, A.C.; Sakai, R.; Jordan, S.C. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J. Immunol. 1985, 134, 3032–3035. [PubMed]
29. Alroy, I.; Towers, T.L.; Freedman, L.P. Transcriptional repression of the interleukin-2 gene by vitamin D3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 1995, 15, 5789–5799. [PubMed]
30. Joshi, S.; Pantalena, L.C.; Liu, X.K.; Gaffen, S.L.; Liu, H.; Rohowsky-Kochan, C.; Ichiyama, K.; Yoshimura, A.; Steinman, L.; Christakos, S. et al. 1,25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 2011, 31, 3653–3669. [CrossRef] [PubMed]
31. Cippitelli, M.; Santoni, A. Vitamin D3: A transcriptional modulator of the interferon-gamma gene. Eur. J. Immunol. 1998, 28, 3017–3030. [CrossRef]
32. Cantorna, M.T.; Snyder, L.; Lin, Y.D.; Yang, L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients 2015, 7, 3011–3021. [CrossRef] [PubMed]
33. Hewison, M. Vitamin D and immune function: An overview. Proc. Nutr. Soc. 2012, 71, 50–61. [CrossRef] [PubMed]
34. Vasiliou, J.E.; Lui, S.; Walker, S.A.; Chohan, V.; Xystrakis, E.; Bush, A.; Hawrylowicz, C.M.; Saglani, S.; Lloyd, C.M. Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease. Allergy 2014, 69, 1380–1389. [CrossRef] [PubMed]
35. Unger, W. W.; Laban, S.; Kleijwegt, F.S.; van der Slik, A. R.; Roep, B.O. Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: Differential role for PD-L1. Eur. J. Immunol. 2009, 39, 3147–3159. [CrossRef] [PubMed]
36. Van Belle, T.L.; Vanherwegen, A.S.; Feyaerts, D.; de Clercq, P.; Verstuyf, A.; Korf, H.; Gysemans, C.; Mathieu, C. 1,25-Dihydroxyvitamin D3 and its analog TX527 promote a stable regulatory T cell phenotype in T cells from type 1 diabetes patients. PLoS ONE 2014, 9, e109194. [CrossRef] [PubMed]
37. Jeffery, L.E.; Burke, F.; Mura, M.; Zheng, Y.; Qureshi, O.S.; Hewison, M.; Walker, L.S.; Lammas, D.A.; Raza, K.; Sansom, D.M. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 2009, 183, 5458–5467. [CrossRef] [PubMed]
38. Chang, J.H.; Cha, H.R.; Lee, D.S.; Seo, K.Y.; Kweon, M.N. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of Th17 cells to protect against experimental autoimmune encephalomyelitis. PLoS ONE 2010, 5, e12925. [CrossRef] [PubMed]
39. Colin, E.M.; Asmawidjaja, P.S.; van Hamburg, J.P.; Mus, A.M.; van Driel, M.; Hazes, J.M.; van Leeuwen, J.P.; Lubberts, E. 1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 2010, 62, 132–142. [CrossRef] [PubMed]
40. Palmer, M.T.; Lee, Y.K.; Maynard, C.L.; Oliver, J.R.; Bikle, D.D.; Jetten, A.M.; Weaver, C.T. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J. Biol. Chem. 2011, 286, 997–1004. [CrossRef] [PubMed]
41. Penna, G.; Adorini, L. 1,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000, 164, 2405–2411. [CrossRef] [PubMed]
42. Griffin, M.D.; Lutz, W.; Phan, V.A.; Bachman, L.A.; McKean, D.J.; Kumar, R. Dendritic cell modulation by 1,25-dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2001, 98, 6800–6805. [CrossRef] [PubMed]
43. Canning, M.O.; Grotenhuis, K.; de Wit, H.; Ruwhof, C.; Drexhage, H.A. 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) hampers the maturation of fully active immature dendritic cells from monocytes. Eur. J. Endocrinol. 2001, 145, 351–357. [CrossRef] [PubMed]
44. D’Ambrosio, D.; Cippitelli, M.; Cocciolo, M.G.; Mazzeo, D.; di Lucia, P.; Lang, R.; Sinigaglia, F.; Panina-Bordignon, P. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Investig. 1998, 101, 252–262. [CrossRef] [PubMed]
45. Simpson, S.J.; Blizzard, L.; Otahal, P.; van der Mei, I.; Taylor, B. Latitude is significantly associated with the prevalence of multiple sclerosis: A meta-analysis. J. Neurol. Neurosurg. Psychiatry 2011, 82, 1132–1141. [CrossRef] [PubMed]
46. Szilagyi, A.; Leighton, H.; Burstein, B.; Xue, X. Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: The inflammatory bowel disease model. Clin. Epidemiol. 2014, 6, 183–198. [CrossRef] [PubMed]
47. Cantorna, M.T.; Mahon, B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp. Biol. Med. (Maywood) 2004, 229, 1136–1142. [PubMed]
48. Munger, K.L.; Levin, L.I.; Hollis, B.W.; Howard, N.S.; Ascherio, A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296, 2832–2838. [CrossRef] [PubMed]
49. Ulitsky, A.; Ananthakrishnan, A.N.; Naik, A.; Skaros, S.; Zadvornova, Y.; Binion, D.G.; Issa, M. Vitamin D deficiency in patients with inflammatory bowel disease: Association with disease activity and quality of life. JPEN J. Parenter. Enter. Nutr. 2011, 35, 308–316. [CrossRef] [PubMed]
50. Hauser, S.L.; Weiner, H.L.; Che, M.; Shapiro, M.E.; Gilles, F.; Letvin, N.L. Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation. J. Immunol. 1984, 132, 1276–1281. [PubMed]
51. Becklund, B.R.; Severson, K.S.; Vang, S.V.; DeLuca, H.F. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc. Natl. Acad. Sci. USA 2010, 107, 6418–6423. [CrossRef] [PubMed]
52. Lemire, J.M.; Archer, D.C. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Investig. 1991, 87, 1103–1107. [CrossRef] [PubMed]
53. Cantorna, M.T.; Hayes, C.E.; DeLuca, H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 1996, 93, 7861–7864. [CrossRef] [PubMed]
54. Cantorna, M.T.; Humpal-Winter, J.; DeLuca, H.F. Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J. Nutr. 1999, 129, 1966–1971. [PubMed]
55. Mattner, F.; Smiroldo, S.; Galbiati, F.; Muller, M.; di Lucia, P.; Poliani, P.L.; Martino, G.; Panina-Bordignon, P.; Adorini, L. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D3. Eur. J. Immunol. 2000, 30, 498–508. [CrossRef]
56. Spach, K.M.; Nashold, F.E.; Dittel, B.N.; Hayes, C.E. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177, 6030–6037. [CrossRef] [PubMed]
57. Cantorna, M.T. Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch. Biochem. Biophys. 2012, 523, 103–106. [CrossRef] [PubMed]
58. Meehan, T.F.; DeLuca, H.F. The vitamin D receptor is necessary for 1,25-dihydroxyvitamin D to suppress experimental autoimmune encepthalomyelitis in mice. Arch. Biochem. Biophys. 2002, 408, 200–204. [CrossRef]
59. Wang, Y.; Marling, S.J.; Zhu, J.G.; Severson, K.S.; DeLuca, H.F. Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor. Proc. Natl. Acad. Sci. USA 2013, 109, 8501–8504. [CrossRef] [PubMed]
60. Froicu, M.; Cantorna, M.T. VitaminDand the vitaminDreceptor are critical for control of the innate immune response to colonic injury. BMC Immunol. 2007, 8. [CrossRef] [PubMed]
61. Axelsson, L.G.; Landstrom, E.; Goldschmidt, T.J.; Gronberg, A.; Bylund-Fellenius, A.C. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4(+)-cell depleted, athymic and NK-cell depleted SCID mice. Inflamm. Res. 1996, 45, 181–191. [CrossRef] [PubMed]
62. Dhawan, P.; Hsaio, C.; Yehia, G.; Porta, A.; Lieben, L.; Carmeliet, G.; Christakos, S. Transgenic expression of the vitamin D receptor (VDR) restricted to the ileum, cecum and colon of VDR knockout mice rescues VDR dependent rickets. J. Bone Min. Res. 2012, 27 (Suppl. S1), S34.
63. Wei, R.; Dhawan, P.; Christakos, S. Studies in mice with transgenic expression of the vitamin D receptor (VDR) exclusively in the distal intestine of VDR knockout mice provide evidence for a critical role of intestinal epithelial cells in the suppression of inflammatory bowel disease by 1,25(OH)2D3/VDR. J. Bone Min. Res. 2013, 28 (Suppl. S1), S329.
64. Hinoi, T.; Akyol, A.; Theisen, B.K.; Ferguson, D.O.; Greenson, J.K.; Williams, B.O.; Cho, K.R.; Fearon, E.R. Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res. 2007, 67, 9721–9730. [CrossRef] [PubMed]
65. Christakos, S.; Seth, T.; Hirsch, J.; Porta, A.; Moulas, A.; Dhawan, P. Vitamin D biology revealed through the study of knockout and transgenic mouse models. Annu. Rev. Nutr. 2013, 33, 71–85. [CrossRef] [PubMed]
66. Schepens, M.A.; Schonewille, A.J.; Vinck, C.; van Schothorst, E.M.; Kramer, E.; Hendriks, T.; Brummer, R.J.; Keijer, J.; van der Meer, R.; Bovee-Oudenhoven, I.M. Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats. J. Nutr. 2009, 139, 1525–1533. [CrossRef] [PubMed]
67. Ooi, J.H.; Li, Y.; Rogers, C.J.; Cantorna, M.T. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J. Nutr. 2013, 143, 1679–1686. [CrossRef] [PubMed]
68. Liu, W.; Chen, Y.; Golan, M.A.; Annunziata, M.L.; Du, J.; Dougherty, U.; Kong, J.; Musch, M.; Huang, Y.; Pekow, J. et al. Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis. J. Clin. Investig. 2013, 123, 3983–3996. [CrossRef] [PubMed]
69. Ho, S.; Pothoulakis, C.; Koon, H.W. Antimicrobial peptides and colitis. Curr. Pharm. Des. 2013, 19, 40–47. [PubMed]